THOUGHTS, INSIGHTS, AND PERSPECTIVES.
Insulin’s Next Century: Technology’s role in unlocking the power of insulin
by Eran Bashan, Hygieia CEO and Co-founder One hundred years ago a group of Canadian scientists and physicians discovered insulin. Frederick Banting, J.R. Macleod, Charles Best and James Collip’s historic finding meant the difference between life and death for people with diabetes. Nearly a century later, Hygieia co-founder Dr. Israel Hodish published a paper1 in…
Diabetes discriminates: Why one’s ethnicity can impact the likelihood of developing type 2 diabetes and suffering from its complications
By Israel Hodish, M.D., Ph.D., co-founder and clinical research lead Type 2 diabetes affects about 10% of the general population in the United States. Yet, it occurs in nearly 15% of the Native-American population, nearly 12% of the non-Hispanic black population, and nearly 13% of the Hispanic population, according to the American Diabetes Association. Why…
Insulin Therapy: The How and Why of Dose Changes
By Israel Hodish, M.D., Ph.D., co-founder and clinical research lead Most patients who use insulin therapy use it for type 2 diabetes. Type 2 diabetes is a progressive condition of insulin deficiency, which means that over time the body secretes less and less insulin. During the second decade of the disease, most patients require insulin…
Diabetes and heart disease: How to manage the risk
By Robert Frank, M.D., chief medical officer Although diabetes is a condition of the endocrine system, it also can affect many other systems in the body. For example, there is a strong link between diabetes and cardiovascular disease. In fact, cardiovascular disease is the most prevalent cause of death (mortality) and complications (morbidity) in diabetic…
What We Know About Type 2 Diabetes and the Covid-19 Vaccines
By Robert Frank, MD, Chief Medical Officer, Hygieia As the coronavirus continues to impact lives around the world, the promise of COVID-19 vaccines brings new hope. In the United States, two vaccines are already in use and more are in development. If you have type 2 diabetes, you might be wondering if you should get…
Artificial Intelligence: Just what the doctor ordered
Medicine is the next industry where AI will replicate human decision making By Eran Bashan, Ph.D., Hygieia CEO and co-founder Just as the 2008 recession ushered in an era of unbridled innovation in financial tech, the effects of the COVID-19 pandemic are similarly accelerating a radical shift in medicine. In the last year, as COVID-19…
Insulin Therapy and the Weight Paradox
By Israel Hodish, M.D., Ph.D., endocrinologist and Hygieia co-founder Most patients with adult-onset diabetes or type 2 diabetes will require insulin therapy at some point. Typically, it happens toward the second decade of the disease. In many cases, patients gain weight during the first six to 12 months after they start insulin therapy. On average,…
Good Diabetes Management Does Not Have to Be Expensive
By Israel Hodish, M.D., Ph.D., endocrinologist and Hygieia co-founder One of the complaints I receive from patients is that diabetes is just too expensive to manage. Medications cost a lot of money every month despite insurance coverage. It has been found that about one of every four insulin users rations their doses to reduce cost.…
Poor HbA1c Control is a Medical Emergency
By Israel Hodish, M.D., Ph.D., endocrinologist and Hygieia co-founder As an endocrinologist, I see many patients with long-standing type 2 diabetes. The typical first-time patient in my practice is a man or a woman between age 40 – 60, who has had type 2 diabetes for more than 10 years, is being treated with four…
Six Years Later, Our Vision is Still the Same
Northern Ireland, where Hygieia has a wholly owned subsidiary of which Bashan is managing director. His topic: inventions – specifically, what inventions must do to travel from concept to popular adoption. He was well qualified to speak on this, having just expanded Hygieia’s d-Nav® insulin management program from a small, independent project to an AI-powered…